Format

Send to

Choose Destination
Clin Pharmacol Ther. 2012 Apr;91(4):607-20. doi: 10.1038/clpt.2011.325. Epub 2012 Feb 22.

Current understanding of rheumatoid arthritis therapy.

Author information

1
Division of Rheumatology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada. ines.colmegna@mcgill.ca

Abstract

Progress in understanding the cellular and molecular mechanisms of rheumatoid arthritis (RA), together with the availability of new therapies, has changed the way we think about RA. The paradigm shift in RA therapy has been from controlling symptoms to controlling the disease process with the abrogation of inflammation. Challenges that are still unresolved include the issues in disease prevention, treatment specificity to restore tolerance, approaches to facilitate tissue repair, and treatment optimization to fit the individual patient's disease phenotype and comorbidity context. This review summarizes the pathogenesis-related rationales for the current therapeutic strategies in RA and for emerging therapies and potential approaches to restoring immune tolerance in RA.

PMID:
22357455
DOI:
10.1038/clpt.2011.325
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center